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General characteristics of colicins
Colicins are a subset of the bactericidal proteins known as
bacteriocins, produced by Escherichia coli strains harboring
colicinogenic plasmids. Unlike most bacterial toxins, they exert
their effect against E. coli and closely related bacteria. The
origin and evolution of colicinogeny are still the subject of
controversy. Since colicin production is encoded by plasmids,
it has been seen as a dispensable and nonessential function for
the survival of coliform bacteria. Nevertheless, the relative
abundance of colicinogenic strains (30%–50%) among E. coli
isolates, and the highly-conserved organization of colicinogenic
genes and amino acid sequences, suggests that they could play
a positive role in the ecology of coliform bacteria [5, 22, 29].
The prevalence of colicinogenic strains in the gastrointestinal
ecosystem could be explained if it were found to benefit the
colonization and defense of an ecological niche occupied or
shared by non-colicinogenic sensitive microorganisms with
similar or identical nutritional requirements.
Colicin synthesis is an inducible system; i.e., it is not
produced under normal circumstances because of a strong
repressive control. When colicinogenic cells are under stressful
conditions or are exposed to physical or chemical agents,
colicin synthesis is derepressed, resulting in an increase in
transcription rates and colicin synthesis [22]. Once the colicin
is produced, it is carried to the extracellular environment,
causing a partial lysis and death of the producer microorganism.
Therefore, colicin production is known as a “suicide”
phenomenon, affecting viability of the induced cell. However,
it becomes a selective advantage for the remainder of the
colicinogenic population, which is protected by a specific
immune mechanism [14].
Colicins are toxins whose molecular sizes range from 29
to 75 kDa. So far, 18 colicins have been identified and classified
according to immunity and resistance. They are: colicin A,
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How bacteria protect themselves
against channel-forming colicins
Summary Here we review the mechanisms that bacterial cells use to protect
themselves against channel-forming colicins. Four mechanisms are examined:
immunity, resistance, tolerance and PacB character. Immunity confers protection to
colicinogenic cells against the colicin they produce, since the colicinogenic plasmid
bears the genetic determinant for such immunity protein. Resistance is provided by
modifications on colicin receptors located on the outer membrane. It prevents colicin
adsorption and protects against those colicins sharing a common receptor. Tolerance
is achieved by changes in the translocation system. The adsorbed colicin is not
translocated toward the periplasmic space. This impedes its insertion into the cell
membrane as well as the formation of the transmembrane channel. Tolerance confers
protection against colicins that share the same translocation system. Finally, we
discuss the PacB character, that confers protection against all known channel-forming
colicins. The latter property is encoded by non-colicinogenic plasmids in the H-
incompatibility complex.
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B, D, E1 to E9, Ia, Ib, K, L, M and N. Based on their mode
of action, colicins have been classified into two major groups:
Enzymatic colicins and Channel-forming colicins. 
Enzymatic colicins kill sensitive cells through degradation
of chromosomal DNA or by protein synthesis inhibition.The
following subgroups have been recognized: Colicins E2, E7,
E8 and E9 are endodeoxyribonucleases. Colicins E3, E4 and
E6 are endoribonucleases. Some colicins, including D and E5,
inhibit protein synthesis.
The mechanism of action of the remaining classified colicins
identified and characterized is common to all of them. They
form ionic channels in the cytoplasmic membrane of the
sensitive bacteria [18]. Colicins A, B, E1, Ia, Ib, K and N belong
to the well defined group of channel-forming colicins.
Channel-forming colicins promote bacterial death by
forming voltage-dependent ionic channels on the cytoplasmic
membrane. After pore formation, the transmembrane elec-
trochemical gradient is disrupted; as a result, the proton force
is dissipated. The main cause of cellular death is the reduction
of the intracellular levels of K+ and Mg2+, and the fugue of ATP
and phosphorylated metabolic intermediaries, which are major
components for the cell [17].
The primary structure of the channel-forming colicin has
allowed polypeptidic chain domains to associate with each
of the events needed for their action (Fig. 1). Thus, the 
N-terminus is involved in translocation through the outer
membrane, whereas the C-terminus is the pore-forming domain,
and the receptor-binding domain is located in the middle of the
protein [2]. Sequence analysis of various channel-forming
colicins (A, B, E1, Ia, Ib, N) revealed a conservation of the 
C-terminal domains [18, 19, 26]. Circular dichroism studies in
ColA show that colicin secondary structure is composed mainly
of α-helix [18, 19, 26]. Crystal structures of several colicins
have been determined. In the case of ColA, ten α-helices were
observed, all of which are amphiphilic except for the highly
hydrophobic central helices (helices 8 and 9). A model has
been proposed to explain the mode of action of colicins, which
suggests a first step of electrostatic binding to the membrane
surface, followed by the insertion of 8 and 9 helices into the
membrane, and insertion of the amphiphilic hairpin helices 5
and 6.
All channel-forming colicins are encoded by plasmids.
The organization of genes involved in colicin synthesis is
highly conserved. Generally, there are three adjacent genes:
the structural gene, the immunity gene and the lysis gene,
coding for colicin, immunity protein and lysis protein,
respectively. The structural and lysis genes constitute an
operon, and the immunity gene is located between these two
genes and is transcribed in the opposite direction from its own
promoter. In ColB, ColIa and ColIb, there are no lysis genes,
but the arrangement of the other two genes is identical to that
previously described. The transcription of the operon
constituted by the structural gene and the lysis gene is strongly
repressed by the binding of the LexA repressor protein. Thus,
under normal circumstances, the colicin cannot be synthesized.
However, the immunity gene is transcribed at low levels [5,
18, 28]. There is a transcription terminator at the end of the
structural gene, which causes the lysis gene to be produced
at a much lower level than the structural gene. When the
system is induced, the lysis gene causes colicin accumulation
within the cell, and colicin exportation begins when the
product of this gene reaches significant levels. The product
of the lysis gene is a protein that is modified post-
transcriptionally to form a lipoprotein that is located in the
inner membrane and is partially outside the cell; this
lipoprotein activates a phospholipase. The outer membrane
becomes permeable, allowing the random release of low
molecular weight proteins including the colicin. The increase
in the permeability of the outer membrane induces a partial
lysis of the colicinogenic cell, leading to its death. Note that
the partial lysis of the colicinogenic cell occurs as a result of
colicin exportation, and not because of the action of
intracellular colicin. Colicin molecules are not able to insert
themselves on the inner side of the membrane, presumably
because the transmembrane potential polarity is contrary to
that required for their correct insertion[18].
Action of channel-forming colicins 
on sensitive bacteria
Channel-forming colicins exert their lethal effects following
a sequence of events: a) the colicin binds to a specific receptor
on the outer membrane of the target cell; b) it is translocated
through the cell envelope; and c) finally, it is inserted in
the membrane and forms the pore or channel that leads to
cell death.
Binding to the receptor Receptors are integral membrane
proteins, that have several transmembrane domains as well
as an external domain exposed to the environment (Table 1).
Nutrient receptors are commonly used by colicins ensuring
their maintenance without other selective pressures. In general,
colicins require a single membrane receptor to be internalized,
with the exception of colicin A, which uses two receptors:
OmpF y BtuB [5].
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Fig. 1 The domains of channel-forming colicins
Table 1 Channel-forming colicins. Activity, immunity, receptor proteins, and
translocation system
Colicin Activity Immunity Receptor Translocation
protein* protein* protein system
A 592 178 BtuB/OmpF Tol system
B 510 175 FepA Ton system
E1 522 113 BtuB Tol system
Ia 626 111 Cir Ton system
Ib 626 115 Cir Ton system
K 548 96 Tsx Tol system
N 387 85 OmpF Ton system
* Number of amino acid residues of the open reading frame.
Translocation through outer membrane Translocation
occurs after the recognition of the colicin outer membrane
receptor. Although colicin absorption follows a first-order
kinetic, which implies that a single colicin molecule can kill a
cell, more than one bound colicin is required to kill a cell.
Apparently, not all bound colicins are translocated through the
cytoplasmic membrane. According to the translocation system
used, channel-forming colicins have been classified into two
groups: group A (colicins A, E1, K) requires the Tol system;
group B (colicins B, Ia, Ib, N) requires the Ton system [18–20]
(Table 1).
The Ton system has three major proteins: TonB, ExbB and
ExbD. TonB is an energy transducer, and uses the transmembrane
electrochemical gradient to take up a variety of nutrients such as
iron and vitamin B12. It was proposed that ExbB and ExbD might
allow TonB to achieve an energized conformation, which would
open translocating channels of the outer membrane. The
interactions of TonB with the outer membrane receptors occurs
through a highly-conserved region in their N-terminus called the
TonB box. [15, 17, 20]. 
The Tol system proteins are located in the sites where inner
membrane and outer membrane are in contact [2]. Four genes,
tolQ, tolR, tolA and tolB, encode these proteins. This non-energy-
dependent system seems to be implicated in the integrity and
preservation of the cell envelope [25]. Nevertheless, it has been
shown that this system is casually used by colicins and phages to
translocate them through outer membrane [20, 39]. Some
components of the Tol system and the TonB system are
homologous. 
Insertion into the cytoplasmatic membrane Channel-
forming colicin activity is located at the C-terminus, which is able
to attach itself electrostatically to the membrane surface and
spontaneously insert itself into it. Models have been proposed to
explain colicin insertion into the cytoplasmic membrane [5, 27].
According to the umbrella model, the hydrophobic helix insertion
is perpendicular to the membrane. In the Penknife model, helices
are in a diagonal position. Once the hydrophobic helices are
inserted, the colicins refold themselves in a way that allows a
channel through the membrane to be formed. Three factors control
the insertion kinetics. First, colicins are strictly dependent on the
lipid-to-protein ratio; secondly, they depend on pH, and finally
they depend on the proportion of negatively charged lipids. The
second and third factors appear to modify the formation of an
insertion-competent state more than the insertion itself [17]. 
A structural study of pore formation has been difficult to carry
out due to its poor stability when it is not in the correct voltage.
Neither direct detection methods, such as Nuclear Magnetic
Resonance (NMR) and X-ray diffraction, nor indirect methods,
such as light spectroscopy, can be applied to the system. Therefore,
only a hypothetical model could be drawn based on biochemical
and biophysical data.
Mechanism of protection against 
channel-forming colicins 
Four protection mechanisms against lethal action of channel-
forming colicin have been reported in bacteria. Three of them,
immunity, resistance and tolerance, have long been recognized
and are well characterized. We ourselves have described the
fourth, PacB, which is currently under study.
Immunity The lethal effect of a channel-forming colicin
is efficiently neutralized by the immunity protein coded by the
same colicinogenic plasmid. The immunity proteins
constitutively expressed by natural colicinogenic plasmids are
membrane proteins with three or four transmembrane domains.
They confer protection against the colicin molecules absorbed
by colicinogenic bacteria, by binding to and inactivating
cytotoxic domains. Intracellular colicin does not have any effect
on the cell that produces it. According to their size, immunity
proteins have been classified into two groups. Type E1 includes
colicins E1, Ia and Ib, which have approximately 113
residues,whereas type A includes colicins A, B and N, which
are larger than E1 type, having approximately 170 residues
(Table 1). Both groups present a high-density charge central
region, and a highly hydrophobic C-terminus. The smallest
homology between immunity proteins is found at their 
N-terminal end [36]. It has been reported that neutralization
occurs through a highly specific interaction between the
immunity protein and the C-terminus of the colicin [9, 18]. The
first of these reports implies the presence of colicins Ia and Ib,
both of which could have been originated from a common
ancestral protein. They are related both structurally and
functionally, and show 60% homology at their C-terminus.
Nevertheless, cells bearing plasmid ColIb show immunity
against ColIb, and are sensitive to ColIa. More evidence of the
specificity of the immunity system has been shown through
research with hybrid colicins ColA and ColE1 [2]. Six hybrid
colicins were constructed, using combinations of ColA and
ColE1 domains (the functional, receptor-binding and
translocation domains). Hybrid colicins bearing the ColA pore-
forming domain were inactive against cells producing ColA
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immunity protein. In addition, hybrid colicins bearing the 
C-terminal domain from ColE1 were innocuous to cells that
produced ColE1 immunity protein.
In order to explain immunity protein specificity, studies of
their topology on the membrane have been carried out, and a
model of colicin A immunity protein organization in the
plasmatic membrane has been suggested. These studies showed
that the modifications that most influence the immune activity
are those located in the periplasmic domain of the polypeptide.
Song and Cramer [36] suggested that immunity protein
specificity was probably due to an interaction with the
translocating apparatus, driving the formation of a ternary
complex between the translocating system. Modification of
hydrophobic amino acids located in the transmembrane regions
impedes the insertion of the immunity protein into the
membrane.
The models proposed suggest that there is a constant lateral
diffusion of the immunity protein in the two-dimensional space
of the cytoplasmic membrane [9, 43]. As soon as an inserted
colicin is recognized, an interprotein helix complex is formed
in which at least one immunity protein transmembrane helix
and two hydrophobic colicin helices interact. This model, which
was applied to the cases of colicins A and B, appears to be the
most important factor in colicin recognition of the immunity
protein.
Resistance The specificity of the colicin-receptor association
has been known for many years. Any alteration of the receptor
precludes the recognition of the colicin, rendering the cell
insensitive to the colicin’s lethal action. This phenomenon,
described in the 1960s, was termed “resistance” [5, 14, 22].
Resistance has been studied by means of microbiological and
molecular analysis of spontaneous and laboratory mutant strains
that have lost their sensitivity to colicin action. These studies
have led to the elucidation of the colicin mode of action, and
have been used as a model for the study of the cell-envelope
proteins. They have also allowed the identification of receptor
proteins that are associated with other functions such as
translocation. Amino acid modifications associated with colicin
resistance are located in areas of the protein exposed to the
extracellular media, and are involved in the recognition process.
These changes cause modifications in the receptor’s three-
dimensional conformation and alterations in the colicin-receptor
interactions that convey resistance phenotype. Experiments in
E. coli strains permit classification of resistant strains into two
groups: those with alterations at the colicin-binding site, and
those with mutations in the receptor motif involved in the colicin
translocation.
Colicin resistance caused by alterations in the receptor may
or may not be related to deficiencies in the receptor’s natural
substrate recognition and assimilation. The areas of the receptor
that participate in both activities are highly related, thus
associating the resistance phenotype with deficiencies in
substrate incorporation [13]. Nevertheless, there are reports of
mutants of protein FepA (receptor of colicin B) where its
receptor activity for enteroqueline is not affected. This suggests
that both mechanisms can be separated [1].
By using bypass treatment, Fourel et al. [10] restored ColA
sensitivity in mutants that did not produce OmpF protein. This
is an evidence of the production of other porines, which permit
the internalization of the colicins under osmotic shock. Fourel
et al. [11] isolated four types of OmpF mutants resistant to
colicin N. The ompF DNA sequence showed alterations in the
receptor amino acid sequence in these mutants. These are
functional changes in the effective binding of the colicin and,
therefore, generate a resistance phenotype. Colicin A and N
use the same receptor, porine OmpF. In vitro studies [8] using
heat and sodium dodecylsulfate denaturalization produce an
unfolded monomeric form, incapable of binding either to ColA
or to ColN, thus ruling out the possibility that the colicin binding
site could be a lineal sequence of the monomer.
Group B colicins and Ton system-dependent receptors
present eight highly conserved amino acids at their N-terminal
end called “TonB box”. Point mutations in the colicin, or in
TonB receptor box lead to the binding, but not to the
translocation, of either the natural substrate or the colicin [24].
Therefore, the latter type of mutant was redefined as one of
those that were mutated in the receptor areas responsible for
interaction with the translocation system. Group B colicins 
N-translocation occurs due to the participation of proteins of
the Tol genes group. Therefore, an interaction is required
between the receptor and these proteins.
When alterations occur in the area associated to
translocation, the resistance could be related to a lower
assimilation or even to the lack of assimilation of the substrate
when the natural substrate is translocated by the same system
as the colicin. 
Finally, resistance to several colicins can be proven when
they share the same receptor. Nevertheless, in channel-forming
colicins, resistance is a limited protection mechanism, which
sometimes can be more effective than immunity.
Tolerance This phenomenon is referred to as the
insensitivity of a non-colicinogenic cell to colicin action.
Tolerance is produced by alterations in the translocation system.
Studies with colicin-tolerant strains have contributed to the
understanding of the organization of E. coli cell envelope. In
this bacteria, Ton and Tol translocation systems facilitate colicin
translocation. The Ton system consists of Ton B, ExbB and
ExbD proteins, which are integral membrane proteins with
periplasmic domains. The Tol system is formed by four proteins
(Tol ABQR), which are probably involved in the cell envelope
maintenance, since no transport function has been associated
[41]. Both systems show functional resemblance and high
homology in the TolQR and ExbBD amino acid sequence at
the transmembrane region [4, 7, 39]. Mutations in Ton or Tol
system proteins prevent the internalization of the adsorbed
colicin, generating a tolerance phenotype.
Two colicin-tolerant cell types have been identified: those
that are mutated in the Ton system and are tolerant to group B
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colicins, and those mutated in the Tol system and are tolerant
to group A colicins. In both translocation mechanisms, the
internalization process is similar, but each colicin has its
particular molecular elements.
The outer membrane of E. coli does not have an energy
source, therefore substrate translocation occurs by energy
transduction. Ton system proteins are involved in this process.
It has been suggested that TonB should be activated when
complexed with ExbD and ExbB. The interaction of the N-
terminal domain with ExbB stabilizes TonB.
Traub et al. [37] identified TonB functional domains, and
located ColIa and ColIb tolerance between residues 181 and
239. A physical interaction area between TonB and the receptors
was also found. In this sense the structural requirements of
colicins Ia and B are, to a certain point, different. Traub et al.
also established that variations surrounding TonB 160 residue
could generate patterns of tolerance to colicins Ia and B. Traub
and Braun [38] found that the area located between residues
13 and 32 was also relevant for colicin B and Ia translocation.
For the Tol translocation system, tolerance patterns with
respect to group A colicins were also determined. Vianney et
al. [39] carried out a mutational analysis of TolQ protein to
determine its role in substrate assimilation and cell-envelope
integrity. Different Tol mutants were found to be tolerant to A
and E1 colicins.
Bacteria with mutations in tolQ, tolR or tolB genes display
a colicin tolerant phenotype that can be overcome by increasing
the colicin concentration (103–104 times). Nevertheless, Tol A
mutants need to eliminate concentrations 106 times higher than
those needed to eliminate a wild-type cell population. This
means, apparently, that TolA is the major protein in the
translocation of group A colicins.
Based on these results, Levengood-Freyermuth et al. [21]
analyzed the structure and cell localization of TolA protein. In
this research it was impossible to determine with precision the
role of TolA in the internalization of group A colicins. However,
it was proposed that the TolA third domain interacts either with
the outer membrane periplasmic proteins or with the colicin-
receptor complex in order to complete the translocation process.
A bridge may form between the outer membrane and the
plasmatic membrane, allowing the transport of molecules
through the cell envelope. This hypothesis fits in with the results
reported by Bénédetti et al. [3], showing that colicins A and
E1 interact with protein TolA in vitro. Moreover, those results
explain why mutations in TolA protein promote such colicin-
tolerant phenotypes.
When mutations occur in the accessory proteins of the
translocation mechanism, partial or total tolerance could appear.
This tolerance acts as a protective mechanism against channel-
forming colicins, but, like resistance, it confers only limited
protection.
PacB character The last of the protective mechanisms
reviewed here is a property that Rodríguez Lemoine calls “PacB
character” (protection against colicin B) [30]. This new property
appears to be unique; it is not a result of colicinogenic plasmid
gene products (immunity proteins) nor of alterations to structural
or functional chromosomal genes (receptor or translocation
genes). Instead, PacB is encoded by non-colicinogenic plasmids,
and restricted to the conspicuous and well-defined H
Incompatibility Complex [27, 30–35]. 
Bacterial sensitivity to lethal action of colicins is routinely
detected by measuring the size of growth-inhibition haloes
formed around a colicinogenic colony. This method was used
to assess the sensitivity of E. coli K12 strains harboring a set
of colicinogenic plasmids. It was found that strains harboring
a set of colicinogenic plasmids of the H incompatibility complex
were less sensitive to the lethal action of colicin B. However,
they maintained their susceptibility to colicins having other
modes of action [31–33].
This phenotype, described as the PacB character, has been
found exclusively among plasmids of the H incompatibility
complex, specifically in groups IncHI (subgroups HI2 and HI3)
and IncHII [31–33]. It appears to be highly conserved among the
IncHI2 plasmids, with the exception of pR476b, a plasmid isolated
from Serratia marcescens. Nevertheless, the PacB character is
absent in plasmids in the IncHI1 subgroup. None of the IncHI1
plasmids kept at the Venezuelan Center for Culture Collections
(Centro Venezolano de Colecciones de Microorganismos, CVCM)
protects E. coli K12 against colicin B.
An additional property has also been demonstrated: E. coli
K12 strains harboring IncH plasmids exhibited reduced
sensitivity not only to colicin B, but also to all channel-forming
colicins A, E1, Ia, Ib, K and N [33]. The protection effect does
not neutralize the cellular lysis caused by colicins M and V [5].
From these results, PacB character has been redefined as a
property encoded by certain IncH plasmids, which confers
protection to E. coli K12 against all channel-forming colicins
[33].
After further research, this character was found to be clearly
associated with the Phi phenotype (reduced efficiency on lytic
plaques formation by bacteriophages as T1, T5, T7 and ϕ80)
and with resistance to tellurium oxianions [33–35]. Since these
properties are proper of plasmids of the H complex, they have
been used as markers for the preliminary identification of
plasmids of this complex. Although detection of both PacB
and tellurite resistance phenotypes leads to the identification
of H plasmids, it does not permit discrimination between  groups
IncHI (subgroups HI2 and HI3) and IncHII. Plasmids of
subgroup IncHI1 are not detected because they do not encode
determinants for PacB and/or Ter properties [26, 34].
The PacB character appears to operate by a mechanism not
related to those of colicinogenic plasmids, which confer highly-
specific immunity protection against a particular colicin
molecule. PacB confers protection against all channel-forming
colicins, regardless of the fact that these colicins are neutralized
by a specific immune protein, or that they use different receptors
to adsorb to outer membranes and/or are translocated into the
cytoplasmic membrane by different translocation systems.
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Although the mode of action of PacB is not known, it is thought
to be closely related to mechanisms for tellurite resistance [35,
40]. Therefore, strategies to explain their mode of action must
take into account linkage of both phenotypes.
Resistance to tellurium compounds is unusual among
Enterobacteriaceae, but whenever present, it has been associated
with plasmids [40, 42]. Nevertheless, cryptic chromosomal
genes encoding low-level resistance have also been reported.
Tellurite resistance (Ter) has been examined in the IncH
plasmids MER610 and R478 (IncHI2), but not in plasmids
from other H-incompatibility subgroups [35]. Although the
regions of these plasmids that code for tellurite resistance (Ter)
have been cloned and sequenced, their biochemical resistance
mechanism remains unknown [42].
In order to understand the PacB character mode of action,
a region of the plasmid Mip233 (IncHI3), encoding the
phenotypes PacB and Ter, has been cloned and studied [35,
40]. Recombinant clones, resistant to ampicillin and potassium
tellurite, have been selected, purified and subcloned. A
PacB+Ter recombinant (pB22) containing a 2200 bp insert,
was cloned. This insert is the smallest DNA segment able
to express a resistance to channel-forming colicins (A and B)
with an efficiency equivalent to that shown by the host strain
carrying plasmid Mip233. PacB and Ter are physically and
genetically linked, forming an operon induced by prior
exposure at subtoxic tellurite levels [35, 40], or by channel-
forming colicins (unpublished results). Linkage of PacB and
Ter has also been established in plasmid R478 [42]. Through
sequence analysis of MER610 and R478 clones, up to seven
open reading frames (ORFs) have been reported, all of which
are necessary to express the Ter function. These clones are
larger than clone pB22. Figure 2 shows the restriction map
of pB22 clone.
To exert their bactericidal effect, potassium tellurite and colicin
molecules must be translocated from the outer membrane to
the cytoplasmic membrane. Therefore, research on the expression
of both properties has been carried out on E. coli strains with
alterations in Ton and Tol translocation systems. Preliminary
results indicate that for the expression of the PacB character, the
intact product of tolC gene is required, since TolC mutants carrying
pB22 are unable to acquire the phenotype PacB-Ter [40].
At present, neither the genetic product(s) of pB22 are known
nor have the mechanisms of action of such product(s) been
elucidated. Nucleotide sequencing of clone pB22 is currently
under way, aimed at establishing the nature of the products
responsible for both phenotypes. Based on preliminary results,
a model is suggested in which genetic product(s) responsible
for the PacB phenotype could have reductase-like activity acting
at the membrane level (Fig. 3).
Concluding remarks
To survive in natural environments where colicins and other
toxin-like products are present, sensitive bacteria must develop
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Fig. 2 The restriction map of pB22 clone
Fig. 3 Model for PacB-Ter resistance mechanism. (A) Colicin molecule binds its receptor and translocates to the inner membrane in which it is inserted to form
a transmembrane channel. (B) The PacB protein (pB22 product) interacts with the cytoplasmic membrane and/or the Tol translocation system proteins, affecting
the colicin C-terminal domain and the ability to produce channels. Its reductase-like activity converts Te2+ to Te0. The region between the outer membrane (OM)
and the inner membrane (IM) is the periplasmic space
mechanisms to protect themselves against these lethal products.
Otherwise, non-colicinogenic bacteria would be at a dis-
advantage when facing those bearing the colicinogenic
determinants. Spontaneous alterations of chromosomal genes
leading to modification of colicin receptor proteins (resistance),
or of translocation systems (tolerance), are among the naturally
selected protective mechanisms. Both resistance and tolerance
exhibit a limited range of protection against channel-forming
colicins. PacB, on the other hand, is a property that confers
protection to E. coli against channel-forming colicins and
against tellurite oxianions. Both are properties encoded in large
plasmids, which are transferable to a wide range of bacteria
[32]. PacB-Ter plasmids frequently code for additional functions,
that contribute indirectly to the maintenance and dissemination
of these properties in natural populations [26, 32, 35]. Thus,
the PacB character could be seen as a major factor for the
survival of cells sharing an ecological niche with channel-
forming colicinogenic strains.
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